Association Between Triglyceride Glucose Index and Triglyceride Glucose-Obesity Composite Indices and the Risk of Ischemic Heart Disease

YANG Jing, ZHU Chenyan, YUAN Lu, ZHANG Tao, LI Jiayuan, JIANG Xia, LONG Lu, LIAO Jiaqiang, MA Tianpei

Abstract

To explore the association between the triglyceride-glucose index (TyG) and TyG-obesity composite indices, including TyG-waist circumference (TyG-WC), TyG-body mass index (TyG-BMI), and TyG-waist-to-height ratio (TyG-WHtR), and the risk of ischemic heart disease (IHD), and to provide reference for the prevention of IHD.

Methods 

The sample of this study was derived from the West China Elderly Preventive and Treatment Merging Cohort, from which 9628 elderly individuals from the retrospective cohort were selected. Cox regression models were used to analyze the association between TyG-related indices and the risk of IHD. Receiver operating characteristic (ROC) curves were plotted to assess and compare the performance of TyG-related indices in predicting the occurrence of IHD.

Results 

The participants were followed up for a median of 2.82 years, with 7.2% (694/9628) of the participants experiencing IHD events. Multivariate Cox regression showed that after controlling for the covariates, including sex, age, educational attainment, smoking, drinking, exercise, dietary habits, medication history, and whether the participant had hypertension, every time TyG, TyG-WC, TyG-BMI and TyG-WHtR increased by one standard deviation (SD), the risk of IHD increased by 12% (hazard ratio [HR]=1.12, 95% confidence interval [CI]: 1.04-1.20), 21% (HR=1.21, 95% CI: 1.12-1.31), 20% (HR=1.20, 95% CI: 1.12-1.29), and 19% (HR=1.19, 95% CI: 1.10-1.28), respectively. Both the TyG index and TyG-obesity composite indices were positively correlated with IHD risk, showing a linear relationship (P<0.05). TyG-WC (area under the curve[AUC]=0.680, 95% CI: 0.660-0.700, P<0.001), TyG-BMI (AUC=0.674, 95% CI: 0.654-0.695, P<0.001), and TyG-WHtR (AUC=0.678, 95% CI: 0.658-0.698, P<0.001) demonstrated better predictive performance than TyG did (AUC=0.669, 95% CI: 0.648-0.689, P<0.001).

Conclusion 

Elevated levels of TyG and TyG-obesity composite indices were associated with a higher risk for IHD, and combining TyG with BMI, WC, and WHtR may lead to better performance in risk assessment for IHD than using TyG alone.

 

Keywords: Insulin resistance, Myocardial ischemia, Obesity, Blood glucose

 

Full Text:

PDF


References


WANG W, LIU Y, LIU J, et al. Mortality and years of life lost of cardiovascular diseases in China, 2005-2020: empirical evidence from national mortality surveillance system. Int J Cardiol, 2021, 340: 105–112. doi: 10.1016/j.ijcard.2021.08.034.

LOPEZ-JARAMILLO P, GOMEZ-ARBELAEZ D, MARTINEZ-BELLO D, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev, 2023, 4(1): e23–e33. doi: 10.1016/S2666-7568(22)00247-1.

RUNDEK T, GARDENER H, XU Q, et al. Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol, 2010, 67(10): 1195–1200. doi: 10.1001/archneurol.2010.235.

MIAO Y, WANG Y, YAN P J, et al. Influencing factors of TyG and its combination with obesity indicators for new-onset ischemic stroke in middle- aged and elderly population: a 10-year follow-up prospective cohort study. Chin Gen Pract, 2022, 25(26): 3232–3239. doi: 10.12114/j. issn.1007-9572.2022.0337.

MIN Y, WEI X, WEI Z, et al. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol, 2024, 23(1): 188. doi: 10.1186/s12933-024-02287-y.

LIM J, KIM J, KOO S H, et al. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007-2010 Korean National Health and Nutrition Examination Survey. PLoS One, 2019, 14(3): e212963. doi: 10.1371/journal.pone.0212963.

LI Y, GUI J, LIU H, et al. Predicting metabolic syndrome by obesity- and lipid-related indices in mid-aged and elderly Chinese: a population-based cross-sectional study. Front Endocrinol (Lausanne), 2023, 14: 1201132. doi: 10.3389/fendo.2023.1201132.

LI X, SUN M, YANG Y, et al. Predictive effect of triglyceride glucose-related parameters, obesity indices, and lipid ratios for diabetes in a Chinese Population: a prospective cohort study. Front Endocrinol (Lausanne), 2022, 13: 862919. doi: 10.3389/fendo.2022.862919.

XUE Y, XU J, LI M, et al. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: triglyceride glucose index-related parameters. Front Endocrinol (Lausanne), 2022, 13: 951689. doi: 10.3389/fendo.2022.951689.

XIONG F, YU C, ZHU L J, et al. Associations between insulin resistance indexes and hyperuricemia in hypertensive population. Acta Academiae Medicinae Sinicae, 2023, 45(3): 390–398. doi: 10.3881/j.issn.1000-503X. 15414.

ER L, WU S, CHOU H, et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS One, 2016, 11(3): e149731. doi: 10.1371/journal.pone.0149731.

XUAN W, LIU D, ZHONG J, et al. Impacts of triglyceride glucose-waist to height ratio on diabetes incidence: a secondary analysis of a population-based longitudinal data. Front Endocrinol (Lausanne), 2022, 13: 949831. doi: 10.3389/fendo.2022.949831.

DANG K, WANG X, HU J, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018. Cardiovasc Diabetol, 2024, 23(1): 8. doi: 10.1186/s12933-023-02115-9.

LI J Y, LONG L, LIANG J Q, et al. The protocol for the West China health and aging cohort study. Mod Prev Med, 2023, 50(6): 961–966. doi: 10. 20043/j.cnki.MPM.202210469.

WEI Y, ZHOU J H, ZHANG Z W, et al. Application of restricted cube spline in cox regression model. Chin J Prev Med, 2020, 54(10): 1169–1173. doi: 10.3760/cma.j.cn112150-20200804-01092.

KUANG M, YANG R, HUANG X, et al. Assessing temporal differences in the predictive power of baseline TyG-related parameters for future diabetes: an analysis using time-dependent receiver operating characteristics. J Transl Med, 2023, 21(1): 299. doi: 10.1186/s12967-023-04159-7.

PARK B, LEE Y, LEE H S, et al. The triglyceride-glucose index predicts ischemic heart disease risk in Koreans: a prospective study using National Health Insurance Service data. Cardiovasc Diabetol, 2020, 19(1): 210. doi: 10.1186/s12933-020-01186-2.

UETANI T, AMANO T, HARADA K, et al. Impact of insulin resistance on post-procedural myocardial injury and clinical outcomes in patients who underwent elective coronary interventions with drug-eluting stents. JACC Cardiovasc Interv, 2012, 5(11): 1159–1167. doi: 10.1016/j.jcin.2012. 07.008.

ZHANG Q, XIAO S, JIAO X, et al. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018. Cardiovasc Diabetol, 2023, 22(1): 279. doi: 10.1186/s12933-023-02030-z.

VASQUES A C J, NOVAES F S, De OLIVEIRA M D S, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract, 2011, 93(3): e98–e100. doi: 10.1016/j.diabres.2011.05.030.

LI R R, SHI X D, CHEN W. A comparative study on the predictive value of new simplified insulin resistance assessment indicators in identifying glucose metabolism disturbance. Chin J Diabet, 2022, 14(1): 56–62. doi: 10.3760/cma.j.cn115791-20210805-00428.


Refbacks

  • There are currently no refbacks.